Literature DB >> 7692784

Role of insulin-like growth factor binding proteins in modifying IGF actions.

D R Clemmons1, J I Jones, W H Busby, G Wright.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 7692784     DOI： 10.1111/j.1749-6632.1993.tb26201.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

1.  Serum levels of insulin-like growth factor-I, -II and insulin-like growth factor binding proteins -2 and -3 in children with acute lymphoblastic leukaemia.

Authors:  K L Mohnike; U Kluba; U Mittler; V Aumann; P Vorwerk; W F Blum
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

Review 2.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 3.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in the NFB4 mutant muscle cell line.

Authors:  D D Sarbassov; R Stefanova; V G Grigoriev; C A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Insulin-like growth factor binding protein 5 enhances survival of LX2 human hepatic stellate cells.

Authors:  Aleksandar Sokolović; Milka Sokolović; Willem Boers; Ronald Pj Oude Elferink; Piter J Bosma
Journal:  Fibrogenesis Tissue Repair       Date:  2010-02-17

6.  Central Infusion of Insulin-Like Growth Factor-1 Increases Hippocampal Neurogenesis and Improves Neurobehavioral Function after Traumatic Brain Injury.

Authors:  Shaun W Carlson; Kathryn E Saatman
Journal:  J Neurotrauma       Date:  2018-04-17       Impact factor: 5.269

7.  Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid.

Authors:  K Swisshelm; K Ryan; K Tsuchiya; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

8.  Dysregulated IGFBP5 expression causes axon degeneration and motoneuron loss in diabetic neuropathy.

Authors:  Christian M Simon; Stefanie Rauskolb; Jennifer M Gunnersen; Bettina Holtmann; Carsten Drepper; Benjamin Dombert; Massimiliano Braga; Stefan Wiese; Sibylle Jablonka; Dirk Pühringer; Jürgen Zielasek; Andreas Hoeflich; Vincenzo Silani; Eckhard Wolf; Susanne Kneitz; Claudia Sommer; Klaus V Toyka; Michael Sendtner
Journal:  Acta Neuropathol       Date:  2015-05-30       Impact factor: 17.088

9.  Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.

Authors:  Vez Repunte-Canonigo; Celine Lefebvre; Olivier George; Tomoya Kawamura; Marisela Morales; George F Koob; Andrea Califano; Eliezer Masliah; Pietro Paolo Sanna
Journal:  Mol Neurodegener       Date:  2014-07-01       Impact factor: 14.195

10.  Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment.

Authors:  Stefanie Rauskolb; Thomas Andreska; Sophie Fries; Cora Ruedt von Collenberg; Robert Blum; Camelia-Maria Monoranu; Carmen Villmann; Michael Sendtner
Journal:  Acta Neuropathol Commun       Date:  2022-05-05       Impact factor: 7.578
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.